Lynx1 Capital Management LP - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Allogene Therapeutics, Inc. (ALLO)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: ALLO
Shares outstanding: 209M shares
Disclosed Ownership: 10.9M shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 09:02 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	5.2%	10.9M	0	10.9M	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	5.2%	10.9M	0	10.9M	/s/ Weston Nichols	Weston Nichols, Individually